22 September 2010

Researchers Identify Markers for Aplastic Anemia Risk

Shorter 'caps' on chromosomes prior to treatment predict higher odds of relapse, death, researchers find

This article has not necessarily been edited by Health24.

This study included 183 patients with severe aplastic anemia who underwent immunosuppressive therapy between 2000 and 2008. The researchers examined changes in the length of the patients' telomeres, which are cap-like structures at the end of chromosomes that protect those ends from deterioration. Telomeres naturally shorten as people age, but their length can also be shortened by genetic factors or environmental stressors.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Live healthier

Lifestyle »

E-cigarettes: Here are five things to know

E-cigarettes have become hugely popular in the past decade, but a rash of vaping-linked deaths and illnesses in the US is feeding caution about a product that's already banned in some places.

Allergy »

Ditch the itch: Researchers find new drug to fight hives

A new drug works by targeting an immune system antibody called immunoglobulin E, which is responsible for the allergic reaction that causes hives.